PhytoDental Solutions announces the appointment of Lisa Giles to its Advisory Board.

| Press Releases

PhytoDental Solutions announces the appointment of Lisa Giles to its Advisory Board.

With more than 20 years of experience in the Life Science industry, Lisa Giles has held various executive roles. In 2000, she launched, Giles & Associates Consultancy (GAC), a professional services firm focus on Strategy Development, Business Intelligence and Analytics, and Transaction Support. For 15 years, GAC has provided strategic consulting services for innovators. Services include product and portfolio optimization, global product launch excellence, market landscape, and commercial and technology assessments across many large, specialty and orphan diseases.

With its team of accomplished industry executives, advisors and analysts, GAC performs both technical and commercial due diligence for market and product growth, competition, adoption, acquisition, divestiture and forecast modeling. In 2013, Giles launched, sister company, Optivara, Inc, which offers a suite of software platforms (SaaS) and content modules.

Prior to GAC and Optivara, Lisa served as the VP of Strategy Development for Searle Pharmaceuticals, a division of Monsanto. There, she led global strategic planning, internal consulting, marketing research, portfolio decision analysis, portfolio optimization, and merger and transaction analysis. Previous to that role, her leadership positions with Abbott Laboratories, Business Strategy Consulting, and Ralston Purina Company. In addition to overseeing the consulting and software practices, Giles has served on many boards, most recently at GenMark Dx (GNMK), Northwestern Memorial Foundation, and the Emeritus Auxiliary Board of the Art Institute of Chicago

About PhytoDental Solutions

PhytoDental Solutions (“PDS”) is dedicated to developing phytocannabinoid-based and augmented formulations for applications across the spectrum of dental diseases and surgical procedures, to provide patients with products of special effect for daily oral care, and at the same time, introducing advanced technology to build a system of precision dentistry to systematically solve the long-standing pain points in the dental and health management industries.

PDS provides a series of professional and consumer products including clinically and statistically validated indication specific formulation products for dental anxiety, denture stomatitis, orthodontic caries and gingivitis, periodontitis, peri-implantitis, pre-, post- dental surgical care, and anti-inflammatory consumer products including toothpaste, dental floss, mouthwash and a series of dental appliances for home use.

PDS indication special formulations are capable of forming a powerful supplement or even replacement for the obvious clinical defects of most products in the dental market.

By promoting the precise application of cannabinoids in dentistry to block the common "oral entrance of pathogens", the systemic health of patients is improved, and an innovative new model of health management - "Dental Health is Well Health" created.

Shopping Cart